Innovation and Productivity
in Pharma and Biotech with AI
AI has the potential to accelerate innovation and enable efficiencies into pharma and biotech. Bringing innovative technologies to market for over 10 years, I have observed first-hand the high quality and reliability requirements that are in these high-stakes settings. I work with pharma, biotech, regulators, technology providers, and industry organizations to ensure deployment of reliable, compliant, and ethical AI.
Key Challenges of AI Implementation in Regulated Industries
Check out these articles that highlight some of the key challenges for AI in regulated industris
RECEIVE ARTICLES AND OTHER NEWS IN YOUR INBOX
About Me
I am passionate about making personalized therapies available to more patients – faster. I believe that unlocking the power of AI and assembling large, comprehensive data sets through collaboration will help accelerate and reduce costs of therapy development and manufacturing. My experience in regulated environments, graduate work in Neuroscience in the lab of a Nobel laureate, and a keen understanding of decision-making have positioned me to develop a privacy-, compliance-, and ethics-focused AI implementation framework. I work with pharma, biotech, regulators, industry associations, and technology providers on identifying and mitigating risks of AI deployment to accelerate path to insights. I have 8 years of academic research experience at MIT and Stanford, 10+ years of strategy and commercialization experience at Thermo Fisher Scientific, at Sartorius, at a number of startups, and working with clients.
